Navamedic ASA: Trade by primary insider
Navamedic ASA: Enters into partnership agreement for distribution of elmiron® in the Nordics
Oslo, August x, 2017 – Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced it has entered into a long term agreement with bene-Arzneimittel GmbH (bene) for the Nordic launch and commercialisation of elmiron®, the only EU approved oral medication used to treat adults with bladder pain syndrome/ Interstitial Cystitis.
Navamedic ASA: Second quarter results 2017
Q2 2017 Presentation